Breaking News Instant updates and real-time market news.

GILD

Gilead

$74.69

0.9 (1.22%)

, KITE

Acquired by GILD 9/17

$178.05

38.95 (28.00%)

07:49
08/29/17
08/29
07:49
08/29/17
07:49

Gilead price target raised to $85 from $79 at Credit Suisse

Credit Suisse analyst Alethia Young raised her price target for Gilead (GILD) to $85 from $79 after adding some Kite Pharma (KITE) platform credit over the long-term. The analyst likes the Kite acquisition and says it marks the beginning of a new chapter. Young reiterates an Outperform rating on Gilead's shares.

GILD

Gilead

$74.69

0.9 (1.22%)

KITE

Acquired by GILD 9/17

$178.05

38.95 (28.00%)

  • 29

    Aug

  • 08

    Sep

  • 11

    Sep

  • 29

    Nov

  • 12

    Feb

GILD Gilead
$74.69

0.9 (1.22%)

08/28/17
NEED
08/28/17
NO CHANGE
NEED
Buy
Gilead's long-term position in oncology unclear, says Needham
Needham analyst Alan Carr says that while the acquisition of Kite Pharma (KITE) creates an opportunity for Gilead Sciences (GILD) to become an important player in oncology, there is enough uncertainty around the technology and the competitive landscape such that it is unclear whether Gilead will emerge a long-term leader in the space. The analyst keeps a Hold rating on Gilead shares.
08/28/17
WELS
08/28/17
NO CHANGE
Target $180
WELS
Market Perform
Wells Fargo sees little chance of higher bid for Kite Pharma
The price paid by Gilead Sciences (GILD) "more than adequately" reflects potential value from Kite Pharma's (KITE) AxiCel and adoptive cellular therapy pipeline, Wells Fargo analyst Jim Birchenough tells investors in a research note. The analyst sees "little chance" of a higher offer or a price bump by Gilead. He raised his price target for Kite shares to $180 and keeps a Market Perform rating on the name. The stock in afternoon trading is just below Gilead's $180 per share takeover offer at $178.12. The shares are up 28% on the day, or $39.02.
08/29/17
ADAM
08/29/17
DOWNGRADE
Target $180
ADAM
Hold
Kite Pharma downgraded to Hold from Buy at Canaccord
Canaccord analyst John Newman downgraded Kite Pharma (KITE) to Hold from Buy after the company agreed to be acquired by Gilead (GILD) for $180 per share.
08/29/17
WEDB
08/29/17
UPGRADE
WEDB
Outperform
Juno Therapeutics upgraded on Kite deal at Wedbush
As noted earlier, Wedbush upgraded Juno (JUNO) to Outperform from Neutral. Analyst David Nierengarten,upgraded Juno following Gilead's (GILD) proposed acquisition of Kite Pharma (KITE). The analyst believes the acquisition serves as validation for the CAR-T cell therapy space and thinks the deal will enhance the awareness of and infrastructure supporting CAR-T therapies by the time Juno's JCAR017 hits the market in late 2018/early 2019. Nierengarten estimates that Juno's pipeline in hematologic malignancies will generate peak U.S. sales of $2B. Target to $42 from $24.
KITE Acquired by GILD 9/17
$178.05

38.95 (28.00%)

08/28/17
GUGG
08/28/17
DOWNGRADE
GUGG
Neutral
Kite Pharma downgraded to Neutral from Buy at Guggenheim
Kite Pharma (KITE) is being acquired by Gilead (GILD) for $180 per share.

TODAY'S FREE FLY STORIES

ADP

ADP

$142.68

-1.02 (-0.71%)

15:45
10/18/18
10/18
15:45
10/18/18
15:45
Options
ADP call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

XOMA

Xoma

$14.38

-1.65 (-10.29%)

, NVS

Novartis

$86.17

0.83 (0.97%)

15:40
10/18/18
10/18
15:40
10/18/18
15:40
Hot Stocks
Breaking Hot Stocks news story on Xoma, Novartis »

Xoma drops 15% after…

XOMA

Xoma

$14.38

-1.65 (-10.29%)

NVS

Novartis

$86.17

0.83 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

XOMA

Xoma

$14.38

-1.65 (-10.29%)

15:39
10/18/18
10/18
15:39
10/18/18
15:39
Hot Stocks
Xoma says Novartis disclosed CRL received from FDA for canakinumab »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWBK

Hawthorn Bancshares

$23.65

(0.00%)

15:36
10/18/18
10/18
15:36
10/18/18
15:36
Hot Stocks
Hawthorn Bancshares to sell Branson, MO branch »

Hawthorn Bank, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDSO

Medidata

$70.82

1.45 (2.09%)

15:36
10/18/18
10/18
15:36
10/18/18
15:36
Recommendations
Medidata analyst commentary  »

Medidata price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ISRG

Intuitive Surgical

$523.21

-19.64 (-3.62%)

15:34
10/18/18
10/18
15:34
10/18/18
15:34
Options
Intuitive Surgical options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

CMCSA

Comcast

$36.11

-0.28 (-0.77%)

15:32
10/18/18
10/18
15:32
10/18/18
15:32
Hot Stocks
Comcast says it is now the largest provider of Gigabit Internet »

Comcast announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PTLA

Portola Pharmaceuticals

$22.02

-1.65 (-6.97%)

15:21
10/18/18
10/18
15:21
10/18/18
15:21
Hot Stocks
Breaking Hot Stocks news story on Portola Pharmaceuticals »

James E. Flynn reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Dec

ETFC

E-Trade

$48.86

-1.71 (-3.38%)

15:19
10/18/18
10/18
15:19
10/18/18
15:19
Options
E Trade options imply 7.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
10/18/18
10/18
15:17
10/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/18/18
10/18
15:16
10/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTZ

Hertz

$15.11

-1.35 (-8.20%)

15:15
10/18/18
10/18
15:15
10/18/18
15:15
Options
Hertz put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

15:10
10/18/18
10/18
15:10
10/18/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

AXP

American Express

$102.92

-1.47 (-1.41%)

15:04
10/18/18
10/18
15:04
10/18/18
15:04
Options
American Express options imply 4.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 05

    Nov

TEVA

Teva

$21.27

0.08 (0.38%)

15:03
10/18/18
10/18
15:03
10/18/18
15:03
Hot Stocks
FDA reports tentative approval for Actavis' ANDA for Pimecrolimus »

Actavis is a unit of Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ACHC

Acadia

$38.63

2.86 (8.00%)

15:03
10/18/18
10/18
15:03
10/18/18
15:03
Recommendations
Acadia analyst commentary  »

Acadia could be worth $43…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISRG

Intuitive Surgical

$525.36

-17.49 (-3.22%)

14:59
10/18/18
10/18
14:59
10/18/18
14:59
Earnings
Fly Intel: What to watch in Intuitive Surgical earnings report »

Intuitive Surgical (ISRG)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

NTAP

NetApp

$78.07

-0.99 (-1.25%)

14:55
10/18/18
10/18
14:55
10/18/18
14:55
Options
NetApp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

14:50
10/18/18
10/18
14:50
10/18/18
14:50
General news
Canada retail sales preview »

Canada retail sales…

14:50
10/18/18
10/18
14:50
10/18/18
14:50
General news
Canada CPI preview »

Canada CPI preview:…

BKD

Brookdale Senior Living

$8.68

-0.07 (-0.80%)

14:49
10/18/18
10/18
14:49
10/18/18
14:49
Hot Stocks
Brookdale Senior Living moves off lows, said to cancel out of conference »

An afternoon move off the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 11

    Dec

PYPL

PayPal

$77.79

-2.32 (-2.90%)

14:49
10/18/18
10/18
14:49
10/18/18
14:49
Options
PayPal options imply 9.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

GOOG

Alphabet

$1,087.23

-28.76 (-2.58%)

, GOOGL

Alphabet Class A

$1,096.20

-30.47 (-2.70%)

14:47
10/18/18
10/18
14:47
10/18/18
14:47
Hot Stocks
Google opens Hardware Stores in NYC and Chicago »

Google opens pop-up…

GOOG

Alphabet

$1,087.23

-28.76 (-2.58%)

GOOGL

Alphabet Class A

$1,096.20

-30.47 (-2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

TTWO

Take-Two

$126.11

-5.89 (-4.46%)

, GME

GameStop

$15.11

-0.23 (-1.50%)

14:47
10/18/18
10/18
14:47
10/18/18
14:47
Periodicals
Smaller game stores may not get 'Red Dead 2' until November, Kotaku says »

Smaller video game…

TTWO

Take-Two

$126.11

-5.89 (-4.46%)

GME

GameStop

$15.11

-0.23 (-1.50%)

BBY

Best Buy

$72.46

-1.37 (-1.86%)

SNE

Sony

$55.85

-2.06 (-3.56%)

MSFT

Microsoft

$108.47

-2.25 (-2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

MDR

McDermott

$14.61

-0.57 (-3.75%)

14:45
10/18/18
10/18
14:45
10/18/18
14:45
Options
McDermott call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.